BRIEF published on 03/29/2026 at 17:10, 6 months 24 days ago FAST III Trial Validates CAAS vFFR as a Competent Alternative to Wire-Based FFR Cardiovascular Care FAST III Trial CAAS VFFR Revascularization Non-Inferiority
PRESS RELEASE published on 03/29/2026 at 17:05, 6 months 24 days ago FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR Pie Medical Imaging announces FAST III trial results: CAAS vFFR shown to be non-inferior to invasive wire-based FFR for guiding revascularization in patients with intermediate coronary stenoses FAST III Trial Pie Medical Imaging VFFR FFR Coronary Stenoses
Published on 10/23/2026 at 02:20, 5 hours 55 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 8 hours 45 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 9 hours 45 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 16 hours 15 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 17 hours 45 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 07:00, 1 hour 15 minutes ago EQS-Adhoc: BB Biotech AG publishes its interim report
Published on 10/23/2026 at 07:00, 1 hour 15 minutes ago ATOSS Software SE: Revenue growth and high profitability in the third quarter put ATOSS on track for another record year
Published on 10/23/2026 at 07:00, 1 hour 15 minutes ago BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment
Published on 10/23/2026 at 06:45, 1 hour 30 minutes ago GURIT REPORTS SOLID THIRD-QUARTER PERFORMANCE AND REITERATES FULL-YEAR GUIDANCE
Published on 10/22/2026 at 18:00, 14 hours 15 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 14 hours 15 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 14 hours 15 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 14 hours 27 minutes ago Aéroports de Paris SA - 2026 9-month revenue
